EyeForPharma, Philadelphia – Chemelle Evans, Vice President at Snow Companies asked panelists from Shire, UCB and AstraZeneca how we can use human connections to chart a new path for our industries. Each had a perspective on how it already is – and what could be next.

Shire: Binge eating disorder

Eric Cline, Director of Marketing, US Neuroscience Business Unit at Shire, shared some big changes they made in a recent indication launch for Vyvanse. He started with a simple observation about human connections:

Today, when patients and providers are together in an office having a discussion, there seems to be a lost connection between them. Time impedes the opportunity to really build empathy with the patient. That leads to a more transactional interaction, missing an opportunity for patients to really share their experience

As brands, we can be a voice for those patients. How can we be their champions despite the lack of time?

That dynamic was really important for Vyvanse because it treats a binge eating disorder, a psychiatric condition. It is a more newly recognized diagnosis. One that doctors didn’t always recognize and patients weren’t aware they were suffering from.

It was easy for Shire to build a rational argument for the disease and how to treat it. But empathy was missing. Why should a physician start this conversation? Why invest the time to get across the shame, stigma, embarrassment that are so typical in mental health?

Shire had to be the champion of those patients, to help their voices be heard. They created a branded patient ambassador program and rolled it out in peer to peer programs. There, patients joined with a KOL to talk about how important the diagnosis was and how treatment changed their lives and relationships.

Shire hosted 150 – 160 P2P programs for well over 1,000 healthcare professionals.

Physicians who initially may have been resistant to the disorder say the programs completely changed the way they think, feel, and will treat BED.

“It’s powerful stuff when you hear physicians who have been practicing for a long time brought to tears by hearing from a patient,” Cline said.

These ambassadors also became part of how Shire builds empathy in the sales force to earn more motivation and advocacy in the field. The patients talked 1:1 with reps, came to sales meetings, and offered teleconferences. Cline explained, “it was a real transfer of passion.”

UCB: Epilepsy

Dakar De La Cruz, Senior Brand Manager of Epilepsy Patients Initiatives at UCB, shared a simple example of how to get people talking about epilepsy with – of all things – a print ad.

The team ran a print ad in the Super Bowl game day program with the call to action to Show Us Your Game Face with the hashtag #tackleepilepsy.

It got people active and involved talking about epilepsy and has continued on long after the campaign.

AstraZeneca: Lung Cancer

Lise Hall, Associate Director of Consumer Marketing Lung Cancer Franchise at AstraZeneca Pharmaceuticals, shared more about the LVNG With program we’ve covered here before.

Hall explained there are differences in how cancers are perceived. “Lung cancer has been left behind. It’s a stigmatized area.” Survivorship is incredibly low (just 17% at 5 years), it’s the #1 cancer killer, and the least funded cancer.

They hear from patients that their biggest challenge isn’t the fear of death. It’s the isolation of the disease. They’re resistant to share because they’re afraid people will think they deserve it.

Hall said, “The first thing they hear is, ‘Did you smoke?’ But people with heart disease aren’t asked ‘Did you eat too many hamburgers’?”

These people need a real human connection.

The LVING With Lung Cancer Facebook page has 137,000 members.

AZ is the facilitator that brings people together to support one another. They’ve found people want to mentor and guide others in a way pharma never could.

Hall shared a lot of examples of how people have healed and connected on the site. One of our favorites: A 61 year old man whose wife just left him was diagnosed with lung cancer. He came to the site and said he didn’t want to go on.

One year later, he posted, “I’m so glad I’m here. You supported me. I find my motivation through you. Thanks to you, I’m here.”

About the Author:

As Managing Director of Innovation and Insights for Syneos Health Communications, Leigh is responsible for building and scaling a global team of healthcare experts who together help life science leaders better understand the complex lives, influences and expectations of their customers. Specifically, they uncover actionable insights that fuel empathy and creativity; lead co-creation events that let marketers learn from peers, trends, and new possibilities; and help clients identify the most valuable and useful new customer experiences to create.

Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly 20 years.She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she held several leadership roles at our largest agency, GSW.  There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business.

Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes.

A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. This year, she led over 250 experts to experts to focus on the most important changes in the commercial, consumer, marketing, digital and healthcare landscapes. (See reports at trends.health)

Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice and Top 10 Innovation Catalysts of 2017 by MM&M, Leigh also was recognized  as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.